Follow Us
https://www.thebody.com/category/prep-hiv-prevention/tag/news-analysis

The Latest

Jaron Benjamin, Lepena Reid, Bryan Jones, and Arianna Lint protest at the U.S. Conference on AIDS (USCA) opening plenary session on Sept. 5

To 'End the HIV Epidemic,' Activists Demand Officials Involve Community in Planning

In a sign of growing frustration with the rollout of the federal Ending the HIV Epidemic plan, dozens of activists stormed the U.S. Conference on AIDS (USCA) opening plenary session on Sept. 5.

Screenshot from Carl Dieffenbach and Anne Rancourt Final IAS 2019 Video

Updates on HIV Treatment Advances and Other Notes From IAS 2019

NIAID's Carl Dieffenbach, Ph.D., joins Anne Rancourt to discuss some key takeaways from the 10th International AIDS Society Conference on HIV Science.

World map and rainbow flag on hands

Why We Need Pride in the Face of Worldwide Oppression, Violence, and HIV

"As we observe this Pride season," writes international HIV advocate George Ayala, "let's embrace human rights and gender equity as inherently critical prerequisites to ending the AIDS pandemic."

Marching with the Equality Flag in Atlanta 2011

In Georgia's Metropolitan Heart, HIV Beats On

Our new "Eyes on the End" series kicks off with an up-close-and-personal glimpse at what's driving the HIV epidemic in the Atlanta metropolitan area.

Alexandria Ocasio-Cortez speaks with members of the PrEP4All advocacy group

Pressure Mounts on Truvada PrEP Pricing With Lawsuit and Congressional Hearings

"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."

PrEP still life, selective focus

Will Recent Gilead Patent Concessions on Truvada Lower PrEP Prices?

Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents Img

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next? Img

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next?

Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find Img

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.